Teva Purinethol (correction)
Executive Summary
In a story on Purinethol (6-mercaptopurine) labeling, "The Pink Sheet" referred to the leukemia drug as a GlaxoSmithKline product ("The Pink Sheet" July 21, 2003, p. 33). Teva received rights to Purinethol July 1 as part of its patent settlement with GSK regarding generics of Relafen (nabumetone) (1"The Pink Sheet" May 5, 2003, In Brief)...